Cargando…
Length of Stay and Costs with Autologous Skin Cell Suspension Versus Split-Thickness Skin Grafts: Burn Care Data from US Centers
INTRODUCTION: Autologous skin cell suspension (ASCS) significantly reduces donor skin requirements versus conventional split-thickness skin grafts (STSG) for thermal burn treatment. In analyses using the Burn-medical counter measure Effectiveness Assessment Cost Outcomes Nexus (BEACON) model, ASCS w...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9472178/ https://www.ncbi.nlm.nih.gov/pubmed/36103088 http://dx.doi.org/10.1007/s12325-022-02306-y |
_version_ | 1784789249897267200 |
---|---|
author | Carter, Jeffrey E. Carson, Joshua S. Hickerson, William L. Rae, Lisa Saquib, Syed F. Wibbenmeyer, Lucy A. Becker, Russell V. Walsh, Thomas P. Sparks, Jeremiah A. |
author_facet | Carter, Jeffrey E. Carson, Joshua S. Hickerson, William L. Rae, Lisa Saquib, Syed F. Wibbenmeyer, Lucy A. Becker, Russell V. Walsh, Thomas P. Sparks, Jeremiah A. |
author_sort | Carter, Jeffrey E. |
collection | PubMed |
description | INTRODUCTION: Autologous skin cell suspension (ASCS) significantly reduces donor skin requirements versus conventional split-thickness skin grafts (STSG) for thermal burn treatment. In analyses using the Burn-medical counter measure Effectiveness Assessment Cost Outcomes Nexus (BEACON) model, ASCS was associated with shorter hospital length of stay (LOS) and cost savings versus STSG. This study hypothesized that daily practice data from the USA would support these findings. METHODS: Electronic medical record data from 500 healthcare facilities (January 2019–August 2020) were used to match adult patients who received inpatient burn treatment with ASCS (± STSG) to patients treated with STSG alone on the basis of sex, age, percent total body surface area (TBSA), and comorbidities. Based on BEACON analyses, LOS was assumed to represent 70% of total costs and used as a proxy to assess the data. Mean LOS, costs, and the incremental revenue associated with inpatient capacity changes were calculated. RESULTS: A total of 151 ASCS and 2443 STSG patients were identified: 63.0% were male and average age was 44.5 years. Eight-one matches were made between cohorts. LOS was 21.7 days with ASCS and 25.0 days with STSG alone (difference 3.3 days [13.2%]). LOS was lower with ASCS than STSG in four of five TBSA intervals. The LOS difference led to hospital bed cost savings of $25,864 per ASCS patient; overall cost savings were $36,949 per patient. Similar cost savings were observed in TBSA groupings < 20% and ≥ 20%. The reduced LOS with ASCS translated into an increased capacity of 2.2 inpatients/bed annually, which increased hospital revenue by $92,283/burn unit bed annually. CONCLUSIONS: Real-world data show that ASCS (± STSG) is associated with reduced LOS and cost savings versus STSG alone across all burn sizes, supporting the validity of the BEACON analyses. ASCS use may also increase patient capacity and throughput, leading to increased hospital revenue. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s12325-022-02306-y. |
format | Online Article Text |
id | pubmed-9472178 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Springer Healthcare |
record_format | MEDLINE/PubMed |
spelling | pubmed-94721782022-09-14 Length of Stay and Costs with Autologous Skin Cell Suspension Versus Split-Thickness Skin Grafts: Burn Care Data from US Centers Carter, Jeffrey E. Carson, Joshua S. Hickerson, William L. Rae, Lisa Saquib, Syed F. Wibbenmeyer, Lucy A. Becker, Russell V. Walsh, Thomas P. Sparks, Jeremiah A. Adv Ther Original Research INTRODUCTION: Autologous skin cell suspension (ASCS) significantly reduces donor skin requirements versus conventional split-thickness skin grafts (STSG) for thermal burn treatment. In analyses using the Burn-medical counter measure Effectiveness Assessment Cost Outcomes Nexus (BEACON) model, ASCS was associated with shorter hospital length of stay (LOS) and cost savings versus STSG. This study hypothesized that daily practice data from the USA would support these findings. METHODS: Electronic medical record data from 500 healthcare facilities (January 2019–August 2020) were used to match adult patients who received inpatient burn treatment with ASCS (± STSG) to patients treated with STSG alone on the basis of sex, age, percent total body surface area (TBSA), and comorbidities. Based on BEACON analyses, LOS was assumed to represent 70% of total costs and used as a proxy to assess the data. Mean LOS, costs, and the incremental revenue associated with inpatient capacity changes were calculated. RESULTS: A total of 151 ASCS and 2443 STSG patients were identified: 63.0% were male and average age was 44.5 years. Eight-one matches were made between cohorts. LOS was 21.7 days with ASCS and 25.0 days with STSG alone (difference 3.3 days [13.2%]). LOS was lower with ASCS than STSG in four of five TBSA intervals. The LOS difference led to hospital bed cost savings of $25,864 per ASCS patient; overall cost savings were $36,949 per patient. Similar cost savings were observed in TBSA groupings < 20% and ≥ 20%. The reduced LOS with ASCS translated into an increased capacity of 2.2 inpatients/bed annually, which increased hospital revenue by $92,283/burn unit bed annually. CONCLUSIONS: Real-world data show that ASCS (± STSG) is associated with reduced LOS and cost savings versus STSG alone across all burn sizes, supporting the validity of the BEACON analyses. ASCS use may also increase patient capacity and throughput, leading to increased hospital revenue. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s12325-022-02306-y. Springer Healthcare 2022-09-14 2022 /pmc/articles/PMC9472178/ /pubmed/36103088 http://dx.doi.org/10.1007/s12325-022-02306-y Text en © The Author(s) 2022 https://creativecommons.org/licenses/by-nc/4.0/Open AccessThis article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) . |
spellingShingle | Original Research Carter, Jeffrey E. Carson, Joshua S. Hickerson, William L. Rae, Lisa Saquib, Syed F. Wibbenmeyer, Lucy A. Becker, Russell V. Walsh, Thomas P. Sparks, Jeremiah A. Length of Stay and Costs with Autologous Skin Cell Suspension Versus Split-Thickness Skin Grafts: Burn Care Data from US Centers |
title | Length of Stay and Costs with Autologous Skin Cell Suspension Versus Split-Thickness Skin Grafts: Burn Care Data from US Centers |
title_full | Length of Stay and Costs with Autologous Skin Cell Suspension Versus Split-Thickness Skin Grafts: Burn Care Data from US Centers |
title_fullStr | Length of Stay and Costs with Autologous Skin Cell Suspension Versus Split-Thickness Skin Grafts: Burn Care Data from US Centers |
title_full_unstemmed | Length of Stay and Costs with Autologous Skin Cell Suspension Versus Split-Thickness Skin Grafts: Burn Care Data from US Centers |
title_short | Length of Stay and Costs with Autologous Skin Cell Suspension Versus Split-Thickness Skin Grafts: Burn Care Data from US Centers |
title_sort | length of stay and costs with autologous skin cell suspension versus split-thickness skin grafts: burn care data from us centers |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9472178/ https://www.ncbi.nlm.nih.gov/pubmed/36103088 http://dx.doi.org/10.1007/s12325-022-02306-y |
work_keys_str_mv | AT carterjeffreye lengthofstayandcostswithautologousskincellsuspensionversussplitthicknessskingraftsburncaredatafromuscenters AT carsonjoshuas lengthofstayandcostswithautologousskincellsuspensionversussplitthicknessskingraftsburncaredatafromuscenters AT hickersonwilliaml lengthofstayandcostswithautologousskincellsuspensionversussplitthicknessskingraftsburncaredatafromuscenters AT raelisa lengthofstayandcostswithautologousskincellsuspensionversussplitthicknessskingraftsburncaredatafromuscenters AT saquibsyedf lengthofstayandcostswithautologousskincellsuspensionversussplitthicknessskingraftsburncaredatafromuscenters AT wibbenmeyerlucya lengthofstayandcostswithautologousskincellsuspensionversussplitthicknessskingraftsburncaredatafromuscenters AT beckerrussellv lengthofstayandcostswithautologousskincellsuspensionversussplitthicknessskingraftsburncaredatafromuscenters AT walshthomasp lengthofstayandcostswithautologousskincellsuspensionversussplitthicknessskingraftsburncaredatafromuscenters AT sparksjeremiaha lengthofstayandcostswithautologousskincellsuspensionversussplitthicknessskingraftsburncaredatafromuscenters |